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INTRODUCTION
Surgical resection has been the cornerstone of curative treat-
ment despite major advances in the multidisciplinary man age-
ment of rectal cancer. For low rectal cancer, abdominoperineal 
resection (APR) had been considered the gold standard since 
Miles reported the technique in 1908. However, patients are left 
with a permanent stoma after APR, which could compromise 
their quality of life. Additionally, some reports have suggested 
that the rate of a positive circumferential resection margin 
(CRM) after APR is high, leading to higher local recurrence rates 
than with low anterior resection (LAR) [1-3]. Extralevator APR, 
which adopts Miles’ original principles, avoids “waisting” of 
the specimen with a consequent risk of CRM involvement [4,5]. 
This enhanced radical approach involves dissecting the levator-
ani muscles at their origin, and removing them en bloc with the 
rectum and anus. However, this technique was associated with 
high perineal morbidities and presented a higher rate of CRM 
positivity than LAR [6,7].
With incremental understanding of tumor biology and the 
Purpose: Tumors at the level of the anorectal junction had required total levator-ani muscle excision to achieve an 
adequate resection margin. However, in the cases of tumor invading ipsilateral levator-ani muscle and intact external 
sphincter, en bloc resection of rectum with levator-ani muscle including tumor would be possible. This hemilevator 
excision (HLE) technique enables preserving the anal sphincter function while obtaining oncologic clearance and avoiding 
permanent colostomy in those patients. This study aimed to evaluate the surgical outcomes and feasibility of HLE.
Methods: Data on 13 consecutive patients who underwent HLE for pathologically proven low rectal cancer were 
retrospectively collected. All 13 patients presented low rectal cancer at the anorectal ring level that was suspected to 
invade or abut to the ipsilateral side of the levator-ani muscle.
Results: A secure resection margin was achieved in all cases, and anastomotic leakage occurred in 2 patients. During 
follow-up, 3 patients experienced tumor recurrence (2 systemic and 1 local). Among 6 patients who underwent diverting 
ileostomy closure after the index operation, 2 complained of fecal incontinence. The other 4 patients without fecal 
incontinence showed <10 times of bowel movement per day. Accessing their incontinence scale, mean Wexner score was 
9.4.
Conclusion: HLE is a novel sphincter-preserving technique that can be a treatment option for low rectal cancer invading 
ipsilateral levator-ani muscle, which has been an indication for abdominoperineal resection (APR) or extralevator APR. 
However, the long-term oncologic and functional outcomes of this procedure still need to be assessed to confirm its 
validity.
[Ann Surg Treat Res 2017;93(4):195-202]














Received February 7, 2017, Revised April 17, 2017, Accepted April 21, 2017
Corresponding Author: Nam Kyu Kim
Department of Surgery, Severance Hospital, Yonsei University College of 
Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-2228-2100, Fax: +82-2-313-8289
E-mail: namkyuk@yuhs.ac
Copyright ⓒ 2017, the Korean Surgical Society
cc  Annals of Surgical Treatment and Research is an Open Access Journal. All 
articles are distributed under the terms of the Creative Commons Attribution Non-
Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which 
permits unrestricted non-commercial use, distribution, and reproduction in any 
medium, provided the original work is properly cited.
196
Annals of Surgical Treatment and Research 2017;93(4):195-202
anatomy of the anal sphincter complex and more prevalent pre-
operative chemoradiation, sphincter-preserving procedures have 
been proposed and adopted—consisting of 2 procedures: ultra-
LAR followed by coloanal anastomosis (CAA) with or with out 
intersphincteric resection (ISR)—since Schiessel et al. reported 
the first ISR with CAA for low rectal cancers in the early 
1990s [8,9]. This procedure is believed to afford an adequate 
oncological resection margin while preserving sphincter 
function, and has been adopted as an alternative to APR.
Despite this surgical improvement, tumors at the level of 
the anorectal junction had required total levator-ani muscle 
ex cision to achieve an adequate CRM. However, in the cases 
of tumor invading limited to ipsilateral levator-ani muscle and 
intact external sphincter, en bloc resection of rectum with 
levator-ani muscle including tumor without compromising anal 
func tion would be possible. Previously, Fucini et al. [10] showed 
the existence of a functional and anatomic separation between 
levator-ani muscle and external anal sphincter. Additionally, 
investi gating rectal cancer patients underwent levator-ani 
muscle excision and sphincter preservation, they suggested that 
selected patients with tumor infiltration limited to the levator-
ani muscle can be treated by this advanced sphincter-sparing 
proce dure with satisfactory oncologic and functional results [11]. 
Recent advances in diagnostic modalities and surgical tech ni-
ques permitted accurate preoperative diagnosis and meticulous 
surgery. Preoperative MRI shows detailed relation between 
tu mor in rectum and surrounding anal sphincter complex, 
which helps to select patients for a specific surgical modality. 
Also, minimally invasive surgeries such as robotic surgery have 
enabled meticulous and precise dissection of the mesorectum 
in a previously irradiated rectum down to the pelvic floor. 
Further more, these techniques permit the manipulation of 
pelvic floor muscles, even their sharp excision. For tumors at 
the level of the levator-ani muscle, excision of the levator-ani 
and achieving a wide resection margin has become possible. 
With this hemilevator excision (HLE) technique followed by 
ISR and CAA, preservation of anal sphincter function while 
obtaining oncologic clearance and avoiding permanent colosto-
my are achievable for the patients with low rectal cancer of 
which infiltration is limited to the ipsilateral levator-ani muscle. 
The proportion of patients in this category might be limited, but 
the possibility of sphincter preservation would be important in 
this challenging field. This study aimed to evaluate the surgical 
outcomes and feasibility of HLE.
METHODS
Between January 2011 and January 2017, we retrospectively 
collected data on 13 consecutive patients who underwent HLE 
for pathologically proven low rectal cancer (within 4 cm from 
the anal verge), performed by a single surgeon. The inclusion 
criteria for this technique were rectal cancer which located 
at the level of anorectal ring and invaded or abutted to the 
ipsilateral levator-ani muscle. The exclusion criteria ruled out 
patients with additional invasion beyond the levator-ani muscle 
to the external anal sphincter, those with recurrent tumor, or 
those with anal cancer. This technique was used to potentially 
avoid permanent colostomy while maintaining oncologic safety 
and anal function. All 13 patients presented low rectal cancer at 
the anorectal ring level that was suspected to invade or abut to 
the ipsilateral side of the levator-ani muscle and/or pelvic floor 
muscles on pelvic MRI, even after preoperative chemoradiation. 
Preoperative chemoradiation was performed for all enrolled 
patients as a long-course radiotherapy: 50.4-Gy radiation in 
28 fractions for 6 weeks concurrent with infusion of 2 cycles 
of 5-fluorouracil- or capecitabine-based chemotherapy (Fig. 
1). The definitive surgery was performed 4–8 weeks after the 
termination of chemoradiation and patients were followed up 
every 3 months after surgery. Postoperative defecation function 
could be assessed for patients who had undergone reversal of 
diverting ileostomy after the index operation and the results on 
last follow-up visit were analyzed. Incontinence was assessed 
by using the patient-reported Cleveland Clinic Florida fecal 
incontinence grading scale, proposed by Jorge and Wexner [12]. 
Patients were informed about the procedure, and all relevant 
preoperative, perioperative, and postoperative data were col-
lected. The study was reviewed and approved by Institutional 
Review Board (IRB) of Severance Hospital (approval number: 




Fig. 1. Comparison of colonoscopic and magnetic reso nance 
imaging before and after chemoradiation. (A) Huge ul ce ro-
fun gating lesion in the low rectum. (B) Partial re gres sion of 
the tumor after chemoradiation. (C) Annular mass involving 
the low rectum with a positive circumferential re sec tion mar-
gin at the left and right levator-ani muscle (white arrows). (D) 
De creased extent of tumor with a still threatening cir cum-
feren tial resection margin at the right levator-ani muscle (white 
arrow).
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IRB waived the requirement for written informed consent.
Operative technique
All patients underwent standard bowel preparation the day 
before surgery and received prophylactic antibiotics before the 
incision. They were placed in the Lloyd-Davies with a steep 
Trendelenburg position. The operation included an abdominal 
and a perineal phase. The abdominal phase included ligation 
of central vessels, mobilization of the splenic flexure, complete 
dissection of the mesorectum, and excision of the levator-
ani muscle. ISR and CAA were performed during the perineal 
phase. Laparoscopic surgery was performed for one patient, and 
others underwent robotic surgery with the da Vinci Surgical 
System (Intuitive Surgical, Sunnyvale, CA, USA).
We started the surgery with colonic mobilization until 
splenic flexure and central vessel ligation. Then, we performed 
dis sec tion of the rectum following the principle of total meso-
rectal excision. Dissection was then continued to the pelvic 
floor consisting of the levator-ani muscles. We exposed the pu-
borec talis muscle at the contralateral side of the tumor. Then, 
dissec tion and excision of the levator-ani on the same side of 
the tumor were performed with a wide margin. After the com-
ple tion of pelvic dissection and HLE, the perineal phase was 
started. The patient’s hips were flexed to allow better access 
to the perineum. The incision started at the line of Hilton on 
the side of the tumor, from where the intersphincteric space 
can be accessed. The dissection then continued between the 
internal and external anal sphincter to the level about 0.5–1 
cm below the tumor, where the direction of the dissection 
turned transversally to include the deep part of the external 
sphincter until the ischiorectal fossa fat could be visualized. 
The dissection continued in a cephalic direction to include the 
leva tor-ani muscle, from where the pelvic cavity is entered. 
In cases of a difficult intersphincteric approach to reach the 
levator-ani muscle attachment, an extrasphincteric approach 
with separate perianal incision parallel to the intersphincteric 
groove was performed to enter the ischiorectal fossa and dissect 
the attachment of the levator-ani muscle. On the contralateral 
side of the tumor, the incision was made just above the dentate 
line and the dissection was in a plane medial to the internal 
sphincter, which allowed entering the pelvic cavity medially 
to the puborectalis muscle (Fig. 2). After total excision of the 
rectum, the rectum and sigmoid colon were delivered through 
the anus and transected as described by Watanabe et al. [13]. 
The distal rectum was divided in a sleeve fashion. Recon struc-
tion of bowel continuity was performed with hand-sewn CAA 
with absorbable interrupted sutures. The level of anastomosis 
between the tumor site and the contralateral side was different 
owing to the sleeve-fashioned resection; on the tumor side, 
the rectum was divided below the sphincter complex, whereas 
division of the rectum on the contralateral side of the tumor 
was done at the level of the anorectal ring. A diverting loop 
ileostomy was created for all patients who underwent this 
technique.


















Fig. 2. Schematic of hemilevator 
ex ci sion. (A) Axial view of the 
extent of resection for hemile va tor 
excision including the rec tum and 
the invaded levator-ani muscle. 
(B) Coronal view of the extent of 
re sec tion for he mile vator excision 
through the intersphincter plane 
and sleeve-fa shioned distal rec-
tum resec tion. (C, D) Cadaveric 
model show ing dissection plane 
for hemile vator excision between 
leva tor-ani muscle and external 
anal sphincter (posterior view 
after sacrum excision).
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RESULTS
Patient characteristics
Thirteen consecutive patients underwent HLE and CAA for 
low rectal cancer. Their characteristics are detailed in Table 1. 
They had a median age of 53.0 years (interquartile range [IQR], 
41.5–65.0 years) and comprised 9 men and 4 women. Their 
median body mass index was 24.0 kg/m2 (IQR, 21.0–27.5 kg/
m2), and the American Society of Anesthesiologists physical 
status classification was I for 2 patients, II for 9 patients, and III 
for 2 patients. The median distance of the primary tumor from 
the anal verge was 3.0 cm (IQR, 2.0–4.0 cm). On preoperative 
imaging such as abdominopelvic CT and pelvic MRI, 8 patients 
showed serosal infiltration of the primary tumor (cT3) and the 
other 5 showed invasion of the tumor into the adjacent levator-
ani muscle (cT4). In all 8 patients with cT3 disease, the primary 
tumor was seen to abut the CRM. Lymph node metastasis 
was suspected on CT and MRI in 11 patients. No patient had 
evidence of distant metastasis on preoperative evaluation. Of 
the 13 patients, 1 underwent laparoscopic surgery, which was 
the initial experience of HLE, and the other 12 underwent 
robotic surgery. All enrolled patients underwent unilateral 
excision of the levator-ani muscle (right side for 4 and left side 
for 9) and 3 patients underwent resection of adjacent organs (e.g., 
vagina and uterus) owing to direct invasion of the tumor. Of 3 
patients with adjacent organ resection, 1 patient required local 
flap transposition to reconstruct the soft tissue defect after 
extensive perineal excision. The median duration of operation 
and amount of blood loss were 321.0 minutes (IQR, 295.5–486.5 
minutes) and 100.0 mL (IQR, 75.0–325.0 mL), respectively.
Pathologic results
The pathologic results of patients are summarized in Table 
2. According to the tumor regression grade after preoperative 
chemo ra diation based on the classification by Mandard et al. 
[14], 2 patients were grade 1 (complete pathologic response), 4 
pa tients were grade 2, 4 patients were grade 3, and 3 patients 
were grade 4. In 3 patients, lymph node metastases were iden-
tified (ypIII). The median tumor size was 1.2 cm (IQR, 0.4–2.8 
cm). For all cases, a secure resection margin from the tumor 
was achieved, especially the CRM, which was the primary 
inten tion of HLE. The definite median distance from the tumor 
to the proximal, distal, and circumferential margin was 20.0, 1.0, 
Table 1. Patient characteristics
Characteristic Value
Age (yr) 53.0 (41.5–65.0)
Sex
  Male 9
  Female 4
Body mass index (kg/m2) 24.0 (21.0–27.5)
ASA PS classification
  I 2
  II 9
  III 2
Tumor location from the anal verge (cm) 3.0 (2.0–4.0)
Preoperative stage
  Tumor infiltration
    cT3 7
    cT4 6
  Lymph node metastasis
    cN0 3
    cN1 8
    cN2 2
  Distant metastasis
    cM0 13
    cM1 0
Surgical method
  Laparoscopic surgery 1
  Robotic surgery 12
Excised side of levator-ani muscle
  Right 4
  Left 9
Duration of operation (min) 321.0 (295.5–486.5)
Intraoperative blood loss (mL) 100 (75.0–325.0)
Values are presented as median (interquartile range) or number.
ASA PS, American Society of Anesthesiologists physical status.
Table 2. Pathologic results
Variable Value
Tumor regression grade (Mandard et al. [14])
  1a) 2
  2 4
  3 4
  4 3
Pathologic stage (ypTNM)
  yp0 2
  ypI 6
  ypII 2
  ypIII 3
Tumor sizeb) (cm) 1.2 (0.5–2.5)
Positive resection margin 0
Distance of resection marginb) (cm)
  Proximal margin 20.0 (15.0–22.0)
  Distal margin 1.0 (0.5–2.0)
  Circumferential margin 0.4 (0.3–1.1)
Lymphovascular invasion 0
Histologic subtype
  Well differentiated 1
  Moderately differentiated 8
  Poorly differentiated type 3
  Mucinous type 1
Values are presented as median (interquartile range) or number.
a)Mandard grade I means complete pathologic response (pCR). 
b)Data for pCR were excluded because of the absence of residual 
tumor.
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and 0.4 cm, respectively. No patient showed lymphovascular 
invasion. Histologically, 1 patient was categorized to have the 
well-differentiated type, 8 moderately differentiated, 3 poorly 
differentiated, and 1 patient had the mucinous type.
Postoperative results 
The median duration of postoperative hospital stay was 8.0 
days (IQR, 8.0–14.5 days). For nine patients, postoperative pelvic 
MRI was performed and excised levator-ani muscle obliterated 
by fibrotic tissue was identified (Fig. 3). Postoperative morbi di-
ties are listed in Table 3. Anastomotic leakage requiring per cu-
taneous drainage occurred in 2 patients. Parastomal her nia for 
diverting ileostomy occurred in 1 patient, followed by revision 
of the stoma. One patient presented acute uri nary retention, 
which was treated with short-term urinary ca theter indwelling 
and medication. The median duration of post opera tive follow-
up was 11.0 months (IQR, 8.5–27.0 months). During follow-up, 
3 patients experienced tumor recurrence. Two patients showed 
systemic recurrence in the lung and liver at 25 and 6 months 
after surgery, respectively. In 1 patient, local re currence at the 
anastomotic site was identified at 4 months after surgery. After 
the index operation, 6 patients underwent reversal of diverting 
ileostomy and others were scheduled for the procedure. Among 
patients who had undergone stomal clo sure, 2 complained of 
fecal incontinence. One patient showed 2 to 3 times of bowel 
movement per day and required a pad for incontinence. The 
other patient showed frequent bowel movements of >10 times 
per day but did not require a pad. The other four patients 
without fecal incontinence showed <10 times of bowel 
movement in a day, which indicated an im prov ing state. Of the 
patients with stomal closure, 5 patients’ Wexner score could be 
assessed. Their mean score was 9.4 ± 5.7.
DISCUSSION
APR had been a primary option for the management of low 
rectal cancer to achieve oncologic clearance. Nowadays, with 
advances in the multimodal treatment of locally advanced rectal 
can cer, anal sphincter preservation has emerged as another 
issue in the management of low rectal cancer. Preoperative 
chemo radiation and ISR with CAA increased the opportunity to 
pre serve the anal sphincter for patients who would otherwise 
be candidates for APR and permanent colostomy. Nevertheless, 
APR is still recommended for patients with rectal cancer infil-
trates in the levator-ani muscle, and managing tumors at this 
level is challenging with a high rate of local recurrence and 
the possibility of combined resection of adjacent structures, 
which might compromise the quality of life. In this study, we 
de scribed our experience of HLE and CAA for selected cases of 
rectal cancer that had invaded the ipsilateral side of the levator-
ani muscle.
Securing a clear resection margin is a major end-point of sur-
gical modalities for low rectal cancer. Recent systemic reviews 
reported the rates of positive CRM after APR and extralevator 
APR to be 13.1%–33.1% and 14.7%–33.1%, respectively [15,16]. In 
this study, although the number of cases was limited, there was 
no patient with positive CRM including the resection margin of 
the levator-ani muscle. Additionally, there was no patient with 
a positive distal resection margin, which suggests the oncolo-
gic safety of HLE. Another concern in performing such a low 
anasto mosis is anastomotic leakage. Two patients (15.4%) in 
the present study experienced anastomotic leakage, and both 
were treated conservatively with percutaneous drainage and 
anti biotics. This result is similar to that of previous studies on 
CAA after resection of low rectal cancer, which reported the 
leakage rate within a range from 5.0% to 21.5% [17-20]. In this 
study, the overall rate of postoperative morbidity was 30.8% and 
there were no mortalities, which was similar to the results in 
other studies on laparoscopic or robotic ISR and CAA [13,21,22]. 
In APR and extralevator APR, a high rate of perineal wound 
complication has been reported (10.7%–59.3%) [16]. HLE did 
not result in a huge perineal defect and the defect of excised 
levator-ani muscle was obliterated by fibrotic tissue, as iden-
tified on pelvic MRI performed after surgery in selected cases. 
The durations of operation and postoperative hospital stay in 
this study were similar or slightly longer than those in other 
reported series on laparoscopic or robotic ISR, which might be 
attributable to the proportion of more advanced disease in this 
Gyoung Tae Noh, et al: Hemilevator excision for rectal cancer invading levator-ani muscle
A B
Fig. 3. Pelvic magnetic resonance imaging after hemilevator 
exci sion: obliterated defect of excised right levator-ani mus-
cle by fibrotic tissue (white arrow). Axial (A) and coronal (B) 
view.




Acute urinary retention 1
Fecal incontinencea) 2
a)Fecal incontinence was assessed in patients underwent stoma 
closure.
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patient group and a wider extent of resection [23,24]. However, 
compared with APR or extralevator APR, the durations of 
operation and postoperative hospital stay were similar or 
relatively shorter after HLE [16,25]. A reason for this result could 
be an absence of a wide perineal wound and its complication in 
patients after HLE.
With technical developments in diagnosis, including imaging 
modalities, preoperative evaluation has become more accurate, 
allowing the establishment of concrete treatment strategies 
in the multimodal treatment era. Furthermore, selection of 
patients for a specific surgical modality has become more 
detailed. The patients in the present study were best diagnosed 
with coronal-axial MRI, which was helpful in determining the 
exact tumor site at the level of the levator-ani muscle. Previously, 
such patients were not well defined, and they typically undergo 
the extensive surgery of APR. For those patients, preservation 
of the anal sphincter might have been possible if they had 
received a multimodal treatment approach, including HLE. Like-
wise, technical developments in surgical instrumentation have 
enabled more delicate operations in pelvic cavity and made 
it possible to achieve HLE with adequate resection margin. 
With the open technique for rectal cancer surgery, exploring 
the pelvic floor for excision of levator-ani muscle is almost 
impossible. Laparoscopic surgery has offered an optimal pelvic 
dissection while keeping the visceral pelvic fascia intact, and 
an enhanced view deeper within the pelvis than with the open 
technique. However, the use of nonarticulated forceps, camera 
tremor, and surgeon fatigue make laparoscopic dissection 
down to the pelvic floor technically challenging, particularly 
in the presence of a narrow pelvis in a male patient, visceral 
obesity, and previous irradiation [21,26,27]. With these tech-
nical obstacles, laparoscopic surgery was restricted to only 
one case of HLE. The recent introduction of robotic systems 
revolutionized the field of minimally invasive surgery [28]. With 
robotic systems, an excellent stereoscopic view may be obtained 
with high illumination, and adequate traction and counter-
traction can be performed readily in a narrow pelvis through 
the endo-wrist function. The adoption of robotic systems, 
which has been used in CAA and ISR as well as in APR, allowed 
over coming the technical limitations of laparoscopic surgery 
during dissection of the levator-ani muscle [19,23]. In a recent 
study comparing surgical outcome between laparoscopic and 
robotic ultra-LAR followed by CAA, there was no significant dif-
fer ence in terms of short- and long-term prognosis and robotic 
sur gery showed superior result in terms of conversion to open 
surgery and length of hospital stay [29]. With these advantages, 
robotic surgery gave us the chance to perform the technically 
challenging surgery of HLE which had not be done by its tech-
nical obstacles.
According to the tumor location and penetration depth to 
adja cent structures such as the sphincter complex and levator-
ani muscle in advanced low rectal cancer, we can suggest 
surgical options if the validity of HLE is confirmed (Fig. 4). 
For rectal cancer around the level of the dentate line, which 
invades only the internal anal sphincter or beyond, ISR through 
the intersphincteric space or APR would be appropriate, re-
A B
C D
Fig. 4. Schematic of surgical op-
tions for advanced rectal can cer. 
(A) Intersphincteric re sec tion for a 
tumor invading only the internal 
sphincter. (B) Abdo min operineal 
re sec tion for a tumor in vading 
be yond the internal sphinc ter. (C) 
Hemile vator ex ci sion for a tumor 
invad ing the levatorani muscle 
with out ex ter nal sphincter inva-
sion. (D) Extra le vator abdo mi no -
pe rineal re sec tion for a tumor in-
vad ing both the levator-ani mus cle 
and ex ternal sphincter muscle.
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spec tively. For low rectal cancer at the level of the anorectal 
ring, which invades the levator-ani muscle, extralevator APR 
is considered an appropriate option. We can subdivide the pa-
tients according to the presence of invasion into the external 
anal sphincter, and for patients without external sphincter inva-
sion, HLE would be feasible to avoid permanent colostomy and 
maintain anal function.
This study has some limitations. First, this was a retro-
spective study with a small population from a single surgeon 
at a single center. A prospective randomized study with a large 
population is needed to confirm that HLE is feasible for low 
rectal cancer invading the levator-ani muscle, instead of APR 
or extralevator APR. Second, long-term oncologic and objective 
functional outcomes need to be elucidated to confirm the 
validity of HLE. The value of results from a short-term follow-
up and small population size would be restrictive. Nevertheless, 
in this study, oncologic safety was assessed with the status of 
the resection margin, and no patient had a positive resection 
margin. Furthermore, although the follow-up period and study 
population were limited, only 1 patient showed local re currence 
(rate, 7.7%). In a previous systemic review, the local re currence 
rate was reported as 10.7% after APR and extra levator APR 
[16]. In the context of functional outcome for the six patients 
who had undergone reversal of diverting ile ostomy, 2 patients 
complained of fecal incontinence. Despite the limited number 
of patients and the short-term follow-up, the rate of continence 
of 66.7% and mean Wexner score of 9.4 was remarkable. 
According to the previous functional results after ISR, perfect 
continence was observed in 51.2% and mean Wexner score was 
10.8 [25,30]. Furthermore, in the previous report investigating 
the functional outcome of levator-ani exci sion for rectal cancer, 
comparing the clinical and laboratory func tion between 
patients with preserved and excised levator-ani muscle, there 
were no significant differences including their mano metric 
results [11].
This study is the first attempt to present surgical method to 
preserve anal sphincter in low rectal cancer invading anorectal 
ring. Despite the limitations of this study as a preliminary 
re port after HLE, the surgical feasibility and oncologic safety 
de scribed here favor the adoption of HLE as an alternative op-
tion instead of APR or extralevator APR for low rectal cancer 
invading the levator-ani muscle. On the basis of anatomical evi-
dence of existing the possible dissecting plane between levator-
ani muscle and external anal sphincter, recent advances in 
pelvic MRI and robotic technology enabled to perform HLE by 
identifying detailed preoperative disease status and conducting 
meticulous excision. Certainly, long-term and functional 
outcomes should be investigated, and further studies will be 
required to validate the procedure of HLE, to better help in the 
management of such patients.
In conclusion, HLE is a novel sphincter-preserving technique 
that can be an alternative treatment for low rectal cancer inva-
ding the ipsilateral side of the levator-ani muscle, which has 
been an indication for APR or extralevator APR. To confirm the 
vali dity of this procedure, long-term oncologic and functional 
out comes need to be assessed.
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